Results 241 to 250 of about 945,221 (295)
Some of the next articles are maybe not open access.

Weakness after Gastric Bypass

Obesity Surgery, 2002
Two patients underwent gastric bypasses and had uneventful hospital courses. In the early postoperative periods, both developed severe, protracted vomiting, weakness, and hyporeflexia. After thorough laboratory and clinical evaluations by neurologists, the patients were diagnosed with Guillain-Barré syndrome, although there were many atypical features.
Craig G, Chang   +3 more
openaire   +2 more sources

Revision of gastric bypass

The American Journal of Surgery, 1980
In this series, 90.6 percent of the patients who had revision of their original gastric bypass for failure to lose satisfactory weight had a significant additional weight loss. The postoperative complication rate was 21.4 percent, and there were no postoperative deaths.
R I, MacArthur   +4 more
openaire   +2 more sources

Postprandial hypoglycaemia after Roux‐en‐Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide

Diabetes, obesity and metabolism, 2019
To investigate the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide on post‐bariatric hypoglycaemia (PBH) after Roux‐en‐Y gastric bypass.
C. Øhrstrøm   +6 more
semanticscholar   +1 more source

Gastric-bypass-induced pneumothorax

Gastrointestinal Radiology, 1985
Substernal gastric bypass has been recently revived to palliate unresectable esophageal carcinoma. We report an unusual postoperative complication of gastric bypass: recurrent pneumothorax responding to nasogastric tube decompression of a distended thoracic stomach.
S J, Pomeranz, J F, Wiot
openaire   +2 more sources

Post–Gastric Bypass Hypoglycemia

Current Diabetes Reports, 2016
Obesity is a major public health problem worldwide. Obesity-related illnesses, such as coronary heart disease, type 2 diabetes, hypertension, dyslipidemia, stroke, sleep apnea, and several forms of cancer (endometrial, breast, and colon), contribute to a significant number of deaths in the USA. Bariatric surgery, including the Roux-en-Y gastric bypass (
Chevon M, Rariy   +2 more
openaire   +2 more sources

Thyrotoxicosis after Gastric Bypass

Obesity Surgery, 2004
Obesity surgery is the optimal therapy for morbid obesity. A case is presented of a young woman who developed thyrotoxicosis, believed to be part of subacute thyroiditis, some days after undergoing laparoscopic Roux-en-Y gastric bypass. This clinical entity can present difficulties in differential diagnosis from potential postoperative complications ...
João Régis I, Carneiro   +2 more
openaire   +2 more sources

Mini-Gastric Bypass Controversy

Obesity Surgery, 2001
© FD-Communications Inc. Obesity Surgery, 11, 2001 773 We have seen numerous operations and innovations introduced in past years with fanfare, only to disappear after a few years, because they contributed no additional benefit for the patient, or were found to cause harm when subjected to longterm follow-up.
B L, Fisher   +9 more
openaire   +2 more sources

Laparoscopic versus open gastric bypass

Seminars in Laparoscopic Surgery, 2002
Laparoscopic bypass has become a common approach for the treatment of morbid obesity. This article compares the results of laparoscopic gastric bypass with that of open gastric bypass based on published data from prospective series, comparative studies, and randomized clinical trials.
Ninh T, Nguyen, Bruce M, Wolfe
openaire   +2 more sources

Effect of gastric bypass on gastric secretion

The American Journal of Surgery, 1976
Gastric bypass as a 90 per cent gastric exclusion operation was used in 393 patients with massive obesity to limit food intake. Stomal ulcer has occurred in 1.8 per cent of such patients or one ulcer per 140 man years of observation. The studies of indwelling fundic pH and of gastric acid secretion from the excluded stomach indicate that acid secretion
E E, Mason   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy